Global Single-Use Bioprocessing Market 2023-2030

Global Single-Use Bioprocessing Market 2023-2030

Global Single-Use Bioprocessing Market Size, Share & Trends Analysis Report by Product (Filtration Assemblies, Media Bags and Containers, Disposable Bioreactors, Disposable Mixers and Other), by Application (Filtration, Cell Culture, Purification and Other), and by End Users (Biopharmaceutical Manufacturers, Academic and Clinical Research Institutes and Other), Forecast Period (2023-2030)

The global single-use bioprocessing market is anticipated to grow at a CAGR of 10.9% during the forecast period (2023-2030). Single-use bioprocessing technology is used in a broad range of biopharmaceutical applications, including filtration, mixing, purification, upstream expression, storage, and separation. The growing adoption of single use bioreactor coupled with advance technology is the key factor supporting the growth of the market globally.The advantage of single-use bioreactors is the flexibility they allow manufacturers. One of the main culprits in downtime is preparing the bioreactor in the upstream process. Single-use bioreactors drastically decrease the time spent preparing the bioreactor for the subsequent batch. Hence, the market players are also focusing on introducing large single-use bioreactors bioprocessing solutions that further bolster the market growth.For instance, in February 2021, WuXi Biologics a global company with open-access biologics technology platforms, announced that its MFG5 Drug Substance (DS) manufacturing facility in China has successfully launched GMP operation, with a capacity of 36,000L, deploying nine 4,000L single-use bioreactors.

Segmental Outlook

The global single-use bioprocessing market is segmented on the product, application, and end users. Based on the product, the market is sub-segmented into filtration assemblies, media bags and containers, disposable bioreactors, disposable mixers and others (disposable filter cartridges). Based on the application, the market is sub-segmented into filtration, cell culture, purification and other (mixing). Further, on the basis of end users, the market is sub-segmented into biopharmaceutical manufacturers, academic and clinical research institutes and others (CROs, CMOs). Among the applications, the filtration sub-segment is anticipated to hold a considerable share of the market owing to the rise in the development of advanced Single-use filtration systems are comprised of a number of fully disposable components, including the entire fluid pathway and filters. This allows for easy and quick adaptation to changing requirements – be it the need for different filter pore sizes or an increased or decreased filling volume.

The Media Bags and Containers Sub-Segment is Anticipated to Hold a Considerable Share of the Global Single-Use Bioprocessing Market

Among the products, the media bags and containers sub-segment is expected to hold a considerable share of the global single-use bioprocessing market. The segmental growth is attributed to the growing uses of single-use bioprocessing technologies that offer several advantages over traditional stainless-steel systems, including reduced cleaning and validation time, increased flexibility, and reduced risk of cross-contamination. Various companies’ extensive expertise in the behavior of different single-use containers and assemblies in critical process steps, such as protection, filling & draining, freezing & thawing, storage and shipping of drug substances, that translated into single-use bags. For instance, in October 2022, Single Use Support GmbH is expanding its product portfolio with new single-use bioprocess containers under the brand name IRIS. The company provide reliable process solutions in the field of biopharmaceutical fluid management, continuing to pursue its vendor-agnostic approach.

Regional Outlook

The global single-use bioprocessing market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America. Among these, Asia-Pacific is anticipated to hold a prominent share of the market across the globe, owing to the adoption of single-use technologies for viral vector and gene therapy production is gaining momentum, driven by the rapid growth of gene-based therapeutics. The key market players include Foxx Life Sciences Pvt. Ltd., Cesco Bioengineering Co. Ltd., PharmNXT Biotech and others

The North America Region is Expected to Grow at a Significant CAGR in the Global Single-Use Bioprocessing Market

Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to an increase in demand for single-use bioprocessing equipment is also driven by an increasing focus on vaccine production to aid in disease prevention measures in the region. single-use bioprocessing technologies for various biopharmaceutical applications have propelled the growth of the market. The adoption of single-use bioprocessing technologies is propelled by the compelling benefits they offer, including reduced risk of cross-contamination, streamlined changeover processes, and faster turnaround times. Additionally, advancements in polymer materials have led to the development of single-use bioreactors that offer cell culture performance at par with stainless steel reactors, further fueling market expansion. Moreover, the presence of the Bio-process System Alliance (BPSA) in North America, that aims at advancing the adoption of single-use technologies, is expected to further drive the sales of disposable systems in the region.

Furthermore, the increasing interest of contract service providers to develop their base in North America, coupled with the trend of implementation of disposables in CMOs, acts as a catalyst for continued investments by local as well as global companies. The key market players include Agilitech Group, Avantor, Inc., Corning Inc., Entegris, Inc., Pall Corp., Thermo Fisher Scientific Inc. and others

Market Players Outlook

The major companies serving the single-use bioprocessing market include Corning Inc., Eppendorf AG, Merck KGaA, Sartorius AG, Thermo Fisher Scientific Inc. and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in January 2020, 3i Group plc launched a single-use bioprocessing platform serving the biopharmaceutical sector with the acquisitions of Cellon, Silicone Altimex and TBL Performance Plastics.The company offer industry products, such as the PharmaTainerTM bottles and carboy product line, aSURE® fittings, Tri-Clamp® ends, Bio-EaseTM clamps, and a wide range of tubing solutions.

The Report Covers

Market value data analysis of 2022 and forecast to 2030.

Annualized market revenues ($ million) for each market segment.

Country-wise analysis of major geographical regions.

Key companies operating in the global single-use bioprocessing market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.

Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.

Analysis of market-entry and market expansion strategies.

Competitive strategies by identifying ‘who-stands-where’ in the market.